Eculizumab effectively reduced MG-ADL scores and corticosteroid use in thymoma-associated myasthenia gravis patients by week 12. The monoclonal antibody targets complement protein C5, preventing ...

The thymus has a key role in inducing acetylcholine receptor antibody production in patients with myasthenia gravis. 64 Many studies have compared the outcomes for patients who undergo thymectomy ...

Myasthenia gravis (MG) ... underscoring the relevance of other mechanisms involved, they observed. "Furthermore, ... (32% had hyperplasia, and none had thymoma).

A new genetic analysis of patients with thymoma-associated myasthenia gravis (THYM-MG) has revealed potential biomarkers associated with follicular helper T (Tfh) cells and B cells, as well as ...

In 1672, Thomas Willis 6 reported the first clinical description of a disease characterized by severe distal muscle weakness. One hundred years later, this disease was termed myasthenia gravis (MG ...

Spotlight On > gMG Myasthenia Gravis Exacerbations — Emerging treatments focus on more precise immune modulation. by Paul Smyth, MD, Contributing Writer, MedPage Today March 7, 2025 • 4 min read ...

Myasthenia gravis 101: ... the new treatment works in a unique way by "preventing the activation of a defective mechanism in the immune ... it is now known that thymus removal helps to gain ...

Generalized myasthenia gravis (gMG) affects most patients through a handful of well-characterized neuromuscular junction autoantibodies, but a wide range of differences among patients affect the ...